These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 27960411)

  • 1. Gemcitabine and Antisense-microRNA Co-encapsulated PLGA-PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy.
    Devulapally R; Foygel K; Sekar TV; Willmann JK; Paulmurugan R
    ACS Appl Mater Interfaces; 2016 Dec; 8(49):33412-33422. PubMed ID: 27960411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precise engineering of hybrid molecules-loaded macromolecular nanoparticles shows
    Liu D; Zhang W; Liu X; Qiu R
    Drug Deliv; 2021 Dec; 28(1):776-786. PubMed ID: 33866910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial and sequential delivery of gemcitabine and oseltamivir phosphate from implantable poly(d,l-lactic-co-glycolic acid) cylinders disables human pancreatic cancer cell survival.
    Allison Logan S; Brissenden AJ; Szewczuk MR; Neufeld RJ
    Drug Des Devel Ther; 2017; 11():2239-2250. PubMed ID: 28814832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Gemcitabine Loaded PLGA/Lecithin Nanoparticles for Non-Small Cell Lung Cancer Therapy.
    Esim O; Ozkan CK; Sarper M; Savaser A; Ozkan Y
    Curr Drug Deliv; 2020; 17(7):622-628. PubMed ID: 32394837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs.
    Mullick Chowdhury S; Wang TY; Bachawal S; Devulapally R; Choe JW; Abou Elkacem L; Yakub BK; Wang DS; Tian L; Paulmurugan R; Willmann JK
    J Control Release; 2016 Sep; 238():272-280. PubMed ID: 27503707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymer Coated Iron Nanoparticles: Radiolabeling & In vitro Studies.
    Yilmaz S; Ichedef C; Karatay KB; Teksöz S
    Curr Radiopharm; 2021; 14(1):37-45. PubMed ID: 32351192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
    Li S; Li X; Ding J; Han L; Guo X
    Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
    [No Abstract]   [Full Text] [Related]  

  • 8. PLGA-based dual targeted nanoparticles enhance miRNA transfection efficiency in hepatic carcinoma.
    Cai C; Xie Y; Wu L; Chen X; Liu H; Zhou Y; Zou H; Liu D; Zhao Y; Kong X; Liu P
    Sci Rep; 2017 Apr; 7():46250. PubMed ID: 28387375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
    Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S
    Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal assessment of ultrasound-guided complementary microRNA therapy of hepatocellular carcinoma.
    Chowdhury SM; Lee T; Bachawal SV; Devulapally R; Abou-Elkacem L; Yeung TA; Wischhusen J; Tian L; Dahl J; Paulmurugan R; Willmann JK
    J Control Release; 2018 Jul; 281():19-28. PubMed ID: 29758233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine Co-Encapsulated with Curcumin in Folate Decorated PLGA Nanoparticles; a Novel Approach to Treat Breast Adenocarcinoma.
    Mukhopadhyay R; Sen R; Paul B; Kazi J; Ganguly S; Debnath MC
    Pharm Res; 2020 Feb; 37(3):56. PubMed ID: 32072346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, evaluation, and
    Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J
    Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of microRNA-21 antisense oligonucleotides and gemcitabine using nanomedicine for pancreatic cancer therapy.
    Li Y; Chen Y; Li J; Zhang Z; Huang C; Lian G; Yang K; Chen S; Lin Y; Wang L; Huang K; Zeng L
    Cancer Sci; 2017 Jul; 108(7):1493-1503. PubMed ID: 28444967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
    Zheng N; Liu W; Li B; Nie H; Liu J; Cheng Y; Wang J; Dong H; Jia L
    J Exp Clin Cancer Res; 2019 May; 38(1):232. PubMed ID: 31151472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
    Srivastava S; Gupta S; Mohammad S; Ahmad I
    J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth in Pancreatic Cancer.
    Ray P; Dutta D; Haque I; Nair G; Mohammed J; Parmer M; Kale N; Orr M; Jain P; Banerjee S; Reindl KM; Mallik S; Kambhampati S; Banerjee SK; Quadir M
    Mol Pharm; 2021 Jan; 18(1):87-100. PubMed ID: 33231464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol-Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non-Small Cell Lung Cancer In Vitro.
    Alibolandi M; Ramezani M; Abnous K; Hadizadeh F
    J Pharm Sci; 2016 May; 105(5):1741-1750. PubMed ID: 27039356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan-PLGA mucoadhesive nanoparticles for gemcitabine repurposing for glioblastoma therapy.
    Ramalho MJ; Serra É; Lima J; Loureiro JA; Pereira MC
    Eur J Pharm Biopharm; 2024 Jul; 200():114326. PubMed ID: 38759897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, Optimization and Toxicity Evaluation of (SPION-PLGA) ±PEG Nanoparticles Loaded with Gemcitabine as a Multifunctional Nanoparticle for Therapeutic and Diagnostic Applications.
    Hamzian N; Hashemi M; Ghorbani M; Bahreyni Toosi MH; Ramezani M
    Iran J Pharm Res; 2017; 16(1):8-21. PubMed ID: 28496458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinational dual drug delivery system to enhance the care and treatment of gastric cancer patients.
    Xiao Y; Gao Y; Li F; Deng Z
    Drug Deliv; 2020 Dec; 27(1):1491-1500. PubMed ID: 33100060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.